665 related articles for article (PubMed ID: 15126416)
1. Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity.
Yamamoto S; Tsuji T; Matsuzaki J; Zhange Y; Chamoto K; Kosaka A; Togashi Y; Sekikawa K; Sawada K; Takeshima T; Koike T; Nishimura T
Int Immunol; 2004 Jun; 16(6):811-7. PubMed ID: 15126416
[TBL] [Abstract][Full Text] [Related]
2. Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors.
Ellison CA; Fischer JM; HayGlass KT; Gartner JG
J Immunol; 1998 Jul; 161(2):631-40. PubMed ID: 9670937
[TBL] [Abstract][Full Text] [Related]
3. Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. Regulation of cytokines and CD8+ lymphoid engraftment.
Fowler DH; Kurasawa K; Husebekk A; Cohen PA; Gress RE
J Immunol; 1994 Feb; 152(3):1004-13. PubMed ID: 7905495
[TBL] [Abstract][Full Text] [Related]
4. Protection from lethal graft-vs.-host disease by donor stem cell repopulation.
Rozendaal L; Pals ST; Melief CJ; Gleichmann E
Eur J Immunol; 1992 Feb; 22(2):575-9. PubMed ID: 1347016
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic analysis of donor cells infiltrating the small intestinal epithelium and spleen during graft-versus-host disease.
Schattenfroh NC; Hoffman RA; McCarthy SA; Simmons RL
Transplantation; 1995 Jan; 59(2):268-73. PubMed ID: 7839451
[TBL] [Abstract][Full Text] [Related]
6. Recovery of T cell populations after acute graft-vs-host reaction.
Hakim FT; Payne S; Shearer GM
J Immunol; 1994 Jan; 152(1):58-64. PubMed ID: 8254206
[TBL] [Abstract][Full Text] [Related]
7. Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host disease.
Ewing P; Miklos S; Olkiewicz KM; Müller G; Andreesen R; Holler E; Cooke KR; Hildebrandt GC
Exp Hematol; 2007 Jan; 35(1):155-63. PubMed ID: 17198884
[TBL] [Abstract][Full Text] [Related]
8. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference.
Moser M; Sharrow SO; Shearer GM
J Immunol; 1988 Apr; 140(8):2600-8. PubMed ID: 3258615
[TBL] [Abstract][Full Text] [Related]
9. Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects.
Ueha S; Murai M; Yoneyama H; Kitabatake M; Imai T; Shimaoka T; Yonehara S; Ishikawa S; Matsushima K
J Leukoc Biol; 2007 Jan; 81(1):176-85. PubMed ID: 17053165
[TBL] [Abstract][Full Text] [Related]
10. Repopulation of host lymphohematopoietic systems by donor cells during graft-versus-host reaction in unirradiated adult F1 mice injected with parental lymphocytes.
Hakim FT; Sharrow SO; Payne S; Shearer GM
J Immunol; 1991 Apr; 146(7):2108-15. PubMed ID: 1672343
[TBL] [Abstract][Full Text] [Related]
11. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
[TBL] [Abstract][Full Text] [Related]
12. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
[TBL] [Abstract][Full Text] [Related]
13. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
Kubota E; Ishikawa H; Saito K
J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
[TBL] [Abstract][Full Text] [Related]
14. Alloimmunization-activated suppressor cells. I: Abrogation of lethal graft-versus-host reaction directed against non-H-2 antigens.
Halle-Pannenko O; Pritchard LL; Rappaport H
Transplantation; 1983 Jul; 36(1):60-8. PubMed ID: 6223422
[TBL] [Abstract][Full Text] [Related]
15. Activation of CD4+ and CD8+ lymphocyte subsets by streptozotocin in the popliteal lymph node assay. II. Comparison with acute graft-vs-host reaction in H-2 incompatible F1 mouse hybrids.
Krzystyniak K; Panaye G; Descotes J; Revillard JP
Immunopharmacol Immunotoxicol; 1992; 14(4):865-82. PubMed ID: 1363474
[TBL] [Abstract][Full Text] [Related]
16. IFN-gamma-mediated prevention of graft-versus-host disease: pharmacodynamic studies and influence on proliferative capacity of chimeric spleen cells.
Brok HP; Vossen JM; Heidt PJ
Bone Marrow Transplant; 1998 Nov; 22(10):1005-10. PubMed ID: 9849699
[TBL] [Abstract][Full Text] [Related]
17. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs-host disease. IV. Activation of donor allosuppressor cells is confined to acute GVHD.
Pals ST; Radaszkiewicz T; Gleichmann E
J Immunol; 1984 Apr; 132(4):1669-78. PubMed ID: 6230390
[TBL] [Abstract][Full Text] [Related]
18. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.
Imamura M; Hashino S; Kobayashi H; Kubayashi S; Hirano S; Minagawa T; Tanaka J; Fujii Y; Kobayashi M; Kasai M
Bone Marrow Transplant; 1994 Jun; 13(6):745-51. PubMed ID: 7920309
[TBL] [Abstract][Full Text] [Related]
19. [Donor-derived TNF-alpha can suppress Th1-dependent CTL generation during acute GVHD in mice].
Yamamoto S
Hokkaido Igaku Zasshi; 2003 Sep; 78(5):429-36. PubMed ID: 14531286
[No Abstract] [Full Text] [Related]
20. An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease.
Welniak LA; Wang Z; Sun K; Kuziel W; Anver MR; Blazar BR; Murphy WJ
Exp Hematol; 2004 Mar; 32(3):318-24. PubMed ID: 15003318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
